Noelyn Kljavin Selected Research

Hypersensitivity (Allergy)

3/2004

Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noelyn Kljavin Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 11/2005
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2016
1	Carcinogenesis 01/2023
1	Genomic Instability 01/2023
1	Colitis 01/2021
1	Hyperplasia 01/2021
1	Infections 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Disease Progression 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2010
1	Hypersensitivity (Allergy) 03/2004

Drug/Important Bio-Agent (IBA)

1	Histones (Histone)IBA 01/2023
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	atezolizumabIBA 01/2023
1	Ligases (Synthetase)IBA 10/2022
1	ZincIBA 10/2022
1	Dextran SulfateIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2020
1	Amino Acids FDA Link 01/2020
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2020
1	Glucagon (Glukagon)FDA Link 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2010
1	CytokinesIBA 01/2010
1	Phosphotransferases (Kinase)IBA 11/2005
1	OligonucleotidesIBA 11/2005
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2005
1	Interleukin-23 (Interleukin 23)IBA 03/2004

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2005
1	Immunotherapy 01/2023
1	Operative Surgical Procedures 01/2020